PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 18 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | – | 19 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 19 | -99.9% | 0.00% | – |
| Q1 2022 | $31,000 | -16.2% | 34,844 | -4.6% | 0.00% | – |
| Q4 2021 | $37,000 | -48.6% | 36,527 | +2.6% | 0.00% | – |
| Q3 2021 | $72,000 | -26.5% | 35,592 | -17.8% | 0.00% | – |
| Q2 2021 | $98,000 | – | 43,325 | +227926.3% | 0.00% | – |
| Q1 2021 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 154,536 | $57,487 | 0.00% |
| UBS Group AG | 23,029 | $8,521 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,398 | $8,332 | 0.00% |
| Cetera Investment Advisers | 75,000 | $27,900 | 0.00% |
| WELLS FARGO & COMPANY/MN | 93 | $35 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 106,917 | $39 | 0.00% |
| MORGAN STANLEY | 1,500 | $558 | 0.00% |
| BlackRock Inc. | 19 | $7 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 19,707 | $7,331 | 0.00% |